Company intelligence / Profile preview

Uscom

Sydney, New South Wales, Australiauscom.com.au ↗

Ownership: Private
Development stage: Other

Overview

Uscom’s non-invasive medical devices are clinically validated and have received regulatory approvals including FDA, CE Marking (Europe), CFDA (China), and TGA (Australia). The company’s products are in commercial use globally in hospitals and clinics for real-time cardiovascular and pulmonary assessment. Over 1000 USCOM 1A units have been sold worldwide.

Therapeutic areas: Infectious DiseasesPulmonologyCardiovascularNeurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Distribution partnerships globally including Vietnam distributor networkpartnership with Australian Wildlife Conservancy as part of CSR initiative

Beyond the preview

Go deeper on Uscom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uscom.

Explore the full profile